Cell Therapy 360 is dedicated to providing solutions-oriented support and knowledge across the Bristol Myers Squibb cell therapy treatment journey, from referral to support services enrollment to infusion and monitoring.
This site provides help with covering the costs of Amgen medicines, including KYPROLIS® (carfilzomib). Amgen Assist can be reached by phone at 1-888-427-7478 or by fax at 1-888-407-9787. They can also be contacted by mail at the following address:
Amgen Assist 360™
PO Box 220354
Charlotte, NC 28222-0354
This site provides qualifying uninsured patients access Amgen medicines at no cost.
This site provides help with navigating the challenges of reimbursement, co-pay assistance, and questions about obtaining Bristol-Myers Squibb (BMS) products such as EMPLICITI® (elotuzumab), REVLIMID® (lenalidomide), POMALYST® (pomalidomide), and THALOMID® (thalidomide).
This site provides help for individuals who cannot afford insurance co-pays for medications to treat cancer.
Sanofi Oncology’s patient support program is committed to helping remove barriers for eligible patients and caregivers as they navigate their treatment journey. The CareASSIST program can offer help with providing information on financial assistance options, navigating potential access challenges, and identifying additional resources to help eligible patients manage the cost and access of medications.
To learn more about the support available through CareASSIST, visit CareASSIST® or call 1-833-WE+CARE (1-833-930-2273).
This site provides information on all Medicare and Medicaid services and programs, including The Affordable Care Act. It is illegal for a plan to deny coverage because a person is sick. Lower costs for prescription drugs in the "donut hole."
Learn about reimbursement support, insurance coverage verification, and product-specific claims and appeals for DARZALEX® (daratumumab). Referrals to independent foundations that may have available funding to help minimize drug costs.
Learn about reimbursement support, insurance coverage verification, and product-specific claims and appeals for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj). Referrals to independent foundations that may have available funding to help minimize drug costs.
This site provides financial assistance program, including copay assistance. It also explains insurance coverage and connects to support services. Visit https://www.genentech-access.com/patient.html or call (877) 436-3683.
Learn about financial assistance for eligible individuals to cover co-insurance, co-payments, healthcare premiums and deductibles for certain medications and therapies.
Janssen has expanded their patient assistance offerings to support insured patients who have inadequate coverage. Beginning January 1, 2023, Janssen medications may be provided free of charge to eligible patients who are insured through commercial, employer-sponsored, or government plans that do not fully meet their needs. Enrollment is now open, and the enrollment form can be downloaded at www.newprograminfo.com. Patients should begin the enrollment process as soon as possible in order to avoid a treatment disruption. If you have any questions, please contact Janssen's dedicated support center at 1-833-742-0791 (Monday through Friday, 8:00 AM to 8:00 PM ET).
The Lenalidomide REMS includes both REVLIMID® (lenalidomide) and generic lenalidomide products/
Teva Generics offers a generic version of lenalidomide, an immunomodulatory drug, used in the newly diagnosed, maintenance therapy, and relapsed and/or refractory myeloma settings.
This program provides assistance toward the cost of private, Medicare, Medicaid, and TRICARE insurance premiums, as well as treatment-related co-pays and co-insurance for prescription drugs, labs, scans, tests, etc. Award levels vary by disease fund.
According to their site, this tool is "a search engine designed to help patients, caregivers, and health care providers learn more about the resources available through the various biopharmaceutical industry programs. MAT is not its own patient assistance program, but rather a search engine for many of the patient assistance resources that the biopharmaceutical industry offers."
Learn more information on programs that help people facing problems paying for medications and healthcare, and assistance with applying to programs.
Learn more about assistance with costs and other day-to-day needs associated with NINLARO® (ixazomib) treatment.
This site provides assistance to underinsured patients for their out-of-pocket expenses for life-saving medications.
Learn about co-pay assistance for pharmaceutical products to qualified insured patients, including Medicare Part D beneficiaries.
Learn about reimbursement support, insurance coverage verification, and product-specific claims and appeals for PROCRIT®(epoetin alfa). Referrals to independent foundations that may have available funding to help minimize drug costs.
Rx Assist is a database of patient assistance programs run by pharmaceutical companies, as well as practical tools, news, and articles.
This site provides details on help for eligible patients regarding access and support for the treatment they’ve been prescribed.
A comprehensive program committed to helping patients taking Takeda Oncology medicines navigate coverage requirements, identify available financial assistance and connect with helpful resources throughout their treatment. The Takeda Oncology Here2Assist™ Patient Support Program is ready to support the needs of patients. Any customer questions should be directed to Takeda Oncology at 1-844-817-6468, Option 2.
Takeda's program for patients, physicians, and caregivers to provide reimbursement assistance related to the use of VELCADE® (bortezomib).
The KaryForward patient support program by Karyopharm has Copay and Patient Assistance programs which can help you with the cost of and access to Xpovio. This program can be reached at www.KaryForward.com or by calling 1-877-527-9493 (1-877-KARY4WD).